Cargando…
Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through OX1R-Nrf2/HIF-1α Pathway
BACKGROUND: Recent studies suggest that there is a potential connection between obstructive sleep apnea (OSA) and osteoporosis through dysregulation of bone metabolism. Orexin-A, a neuroprotective peptide secreted by the hypothalamus, is at a lower level in the plasma of OSA patients, which regulate...
Autores principales: | Gu, Hong, Ru, Yiwen, Wang, Wei, Cai, Guanhui, Gu, Lanxin, Ye, Junjie, Zhang, Wei-Bing, Wang, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270907/ https://www.ncbi.nlm.nih.gov/pubmed/35818538 http://dx.doi.org/10.2147/DDDT.S363286 |
Ejemplares similares
-
OX(1) and OX(2) orexin/hypocretin receptor pharmacogenetics
por: Thompson, Miles D., et al.
Publicado: (2014) -
Kinetic properties of “dual” orexin receptor antagonists at OX(1)R and OX(2)R orexin receptors
por: Callander, Gabrielle E., et al.
Publicado: (2013) -
No evidence of autoimmunity to human OX(1) or OX(2) orexin receptors in Pandemrix-vaccinated narcoleptic children
por: Melén, Krister, et al.
Publicado: (2020) -
Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson’s Disease
por: Liu, Mei-Fang, et al.
Publicado: (2018) -
Intermittent hypoxia enhances the expression of hypoxia inducible factor HIF1A through histone demethylation
por: Martinez, Chloe-Anne, et al.
Publicado: (2022)